Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus
Ying Liu, Joacim Rocklöv
Journal of Travel Medicine (2021) Vol. 28, Iss. 7
Open Access | Times Cited: 556

Showing 1-25 of 556 citing articles:

Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
Anika Singanayagam, Seran Hakki, Jake Dunning, et al.
The Lancet Infectious Diseases (2021) Vol. 22, Iss. 2, pp. 183-195
Open Access | Times Cited: 753
SARS-CoV-2 Omicron variant: recent progress and future perspectives
Yao Fan, Xiang Li, Lei Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 471
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
Pengcheng Han, Linjie Li, Sheng Liu, et al.
Cell (2022) Vol. 185, Iss. 4, pp. 630-640.e10
Open Access | Times Cited: 449
Population Immunity and Covid-19 Severity with Omicron Variant in South Africa
Shabir A. Madhi, Gaurav Kwatra, Jonathan E. Myers, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 14, pp. 1314-1326
Open Access | Times Cited: 385
The effective reproductive number of the Omicron variant of SARS-CoV-2 is several times relative to Delta
Ying Liu, Joacim Rocklöv
Journal of Travel Medicine (2022) Vol. 29, Iss. 3
Open Access | Times Cited: 297
Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation
Brit Long, Brandon M Carius, Summer Chavez, et al.
The American Journal of Emergency Medicine (2022) Vol. 54, pp. 46-57
Open Access | Times Cited: 219
SARS-COV-2 Variants: Differences and Potential of Immune Evasion
Sandro Massao Hirabara, Tamires Duarte Afonso Serdan, Renata Gorjão, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 206
Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
Piotr Rzymski, Barbara Poniedziałek, Andrzej Fal
Vaccines (2021) Vol. 9, Iss. 11, pp. 1286-1286
Open Access | Times Cited: 148
Transmission of SARS-CoV-2 from humans to animals and potential host adaptation
Cedric C.S. Tan, Su Datt Lam, Damien Richard, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 120
Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant
Adeel A. Butt, Soha R. Dargham, Srusvin Loka, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 1, pp. e361-e367
Open Access | Times Cited: 116
Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar
Adeel A. Butt, Soha R. Dargham, Hiam Chemaitelly, et al.
JAMA Internal Medicine (2021) Vol. 182, Iss. 2, pp. 197-197
Open Access | Times Cited: 101
Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?
Bao V. Duong, Puchanee Larpruenrudee, Tianxin Fang, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 8, pp. 4586-4586
Open Access | Times Cited: 91
COVID-19: Challenges of Viral Variants
Jana L. Jacobs, Ghady Haidar, John W. Mellors
Annual Review of Medicine (2022) Vol. 74, Iss. 1, pp. 31-53
Open Access | Times Cited: 84
Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2
Negar Firouzabadi, Parisa Ghasemiyeh, Fatemeh Moradishooli, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109968-109968
Open Access | Times Cited: 74
Role of COVID-19 Vaccines in SARS-CoV-2 Variants
Zhou Zhou, Yimiao Zhu, Ming Chu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 73
Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA.1 variant through NSP6
Taha Y. Taha, Irene P. Chen, Jennifer M. Hayashi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 44
From Alpha to Omicron: How Different Variants of Concern of the SARS-Coronavirus-2 Impacted the World
Mickensone Andre, Lee-Seng Lau, Marissa D. Pokharel, et al.
Biology (2023) Vol. 12, Iss. 9, pp. 1267-1267
Open Access | Times Cited: 43
Evolution of the SARS-CoV-2 Omicron Variants: Genetic Impact on Viral Fitness
Wenhao Liu, Zehong Huang, Jin Xiao, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 184-184
Open Access | Times Cited: 20
COVID-19 Vaccine Boosters: The Good, the Bad, and the Ugly
Piotr Rzymski, Carlos A. Camargo, Andrzej Fal, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1299-1299
Open Access | Times Cited: 76
COVID-19 Delta Variant: Perceptions, Worries, and Vaccine-Booster Acceptability among Healthcare Workers
Khalid Alhasan, Fadi Aljamaan, Mohamad‐Hani Temsah, et al.
Healthcare (2021) Vol. 9, Iss. 11, pp. 1566-1566
Open Access | Times Cited: 69
Maintaining face mask use before and after achieving different COVID-19 vaccination coverage levels: a modelling study
Sarah M. Bartsch, Kelly J. O’Shea, Kevin L. Chin, et al.
The Lancet Public Health (2022) Vol. 7, Iss. 4, pp. e356-e365
Open Access | Times Cited: 62
SARS-CoV-2 Delta (B.1.617.2) Variant: A Unique T478K Mutation in Receptor Binding Motif (RBM) of Spike Gene
Hyunjhung Jhun, Ho‐Young Park, Yasmin Hisham, et al.
Immune Network (2021) Vol. 21, Iss. 5
Open Access | Times Cited: 61
SARS-CoV-2 Omicron Mutation Is Faster than the Chase: Multiple Mutations on Spike/ACE2 Interaction Residues
Sinae Kim, Tam Nguyen, Afeisha S. Taitt, et al.
Immune Network (2021) Vol. 21, Iss. 6
Open Access | Times Cited: 57
The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection
Mathias Martins, Gabriela Mansano do Nascimento, Mohammed Nooruzzaman, et al.
Journal of Virology (2022) Vol. 96, Iss. 17
Open Access | Times Cited: 57
Effectiveness of COVID-19 Vaccines against Delta (B.1.617.2) Variant: A Systematic Review and Meta-Analysis of Clinical Studies
Ali Pormohammad, Mohammad Zarei, Saied Ghorbani, et al.
Vaccines (2021) Vol. 10, Iss. 1, pp. 23-23
Open Access | Times Cited: 56
Page 1 - Next Page

Scroll to top